Literature DB >> 3350236

Altered amount and activity of superoxide dismutase in sickle cell anemia.

L Schacter1, J A Warth, E M Gordon, A Prasad, B L Klein.   

Abstract

The amount and activity of superoxide dismutase (SOD) (EC 1.15.1.1) were measured in red cells collected from 50 white controls, 101 black controls, 50 patients with sickle hemoglobin (SS Hb), 12 with sickle trait, and 11 with other sickling hemoglobinopathies. Red cells from normal black subjects had more SOD amount and activity than normal whites (1.77 U/mg Hb and 2.96 micrograms/mg Hb vs. 1.47 U/mg Hb and 2.64 micrograms/mg Hb, respectively) or blacks with SS Hb or other sickling hemoglobinopathies. Patients with more severe manifestations of SS Hb had lower levels of SOD activity than those with milder symptoms but had the same amount of enzyme protein. Individuals with sickle trait had amounts and activities of SOD comparable to black controls. An alteration in defense to free radical oxygen may play a role in the severity of symptoms experienced by patients with homozygous sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350236     DOI: 10.1096/fasebj.2.3.3350236

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells.

Authors:  Aaron K Holley; Kelley K Kiningham; Douglas R Spitz; Dean P Edwards; Jeffrey T Jenkins; Michael R Moore
Journal:  J Steroid Biochem Mol Biol       Date:  2009-06-27       Impact factor: 4.292

2.  Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.

Authors:  Cristiane O Renó; Amanda Rodrigues Barbosa; Sara Santos de Carvalho; Melina B Pinheiro; Danyelle Romana Rios; Vanessa F Cortes; Leandro A Barbosa; Hérica L Santos
Journal:  Ann Hematol       Date:  2020-03-12       Impact factor: 3.673

3.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

4.  Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice.

Authors:  Samit Ghosh; Chibueze A Ihunnah; Rimi Hazra; Aisha L Walker; Jason M Hansen; David R Archer; Amma T Owusu-Ansah; Solomon F Ofori-Acquah
Journal:  JCI Insight       Date:  2016-04-07

5.  microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.

Authors:  Carolyn Sangokoya; Marilyn J Telen; Jen-Tsan Chi
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

Review 6.  The proteome of sickle cell disease: insights from exploratory proteomic profiling.

Authors:  Susan Yuditskaya; Anthony F Suffredini; Gregory J Kato
Journal:  Expert Rev Proteomics       Date:  2010-12       Impact factor: 3.940

7.  Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia.

Authors:  Chun-Seok Cho; Gregory J Kato; Seung Ha Yang; Sung Won Bae; Jong Seo Lee; Mark T Gladwin; Sue Goo Rhee
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

Review 8.  Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.

Authors:  Erica N Chirico; Camille Faës; Philippe Connes; Emmanuelle Canet-Soulas; Cyril Martin; Vincent Pialoux
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

9.  Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.

Authors:  Claudia R Morris; Jung H Suh; Ward Hagar; Sandra Larkin; D Anton Bland; Martin H Steinberg; Elliott P Vichinsky; Mark Shigenaga; Bruce Ames; Frans A Kuypers; Elizabeth S Klings
Journal:  Blood       Date:  2007-09-11       Impact factor: 22.113

Review 10.  Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease.

Authors:  E S Klings; H W Farber
Journal:  Respir Res       Date:  2001-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.